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Abstract 
Autism is a neurodevelopmental disease that presents in early life. Despite a considerable 
amount of studies, the neurobiological mechanisms underlying autism remain obscure. Both 
genetic and environmental factors are involved in the development of autism. Vitamin D 
deficiency is emerging as a consistently reported risk factor in children. One reason for the 
prominence now being given to this risk factor is that it would appear to interact with several 
other epidemiological risk factors for autism. Vitamin D is an active neurosteroid and plays 
crucial neuroprotective roles in the developing brain. It has important roles in cell 
proliferation and differentiation, immunomodulation, regulation of neurotransmission and 
steroidogenesis. Animal studies have suggested that transient prenatal vitamin D deficiency is 
associated with altered brain development. Here we review the potential neurobiological 
mechanisms linking prenatal vitamin D deficiency and autism and also discuss what future 
research targets must now be addressed.  
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1. Introduction  
Autism comprises a heterogeneous group of disorders together referred to as Autism 
Spectrum Disorders (ASD). ASD includes autistic disorder, Asperger’s syndrome, Rett’s 
syndrome, childhood disintegrative disorder and pervasive developmental disorders not 
otherwise specified. ASD was introduced to Diagnostic and Statistical Manual-III in 1980 
(Mayes and Horwitz 2005). It was first described by the American mental health clinician 
Leo Kanner as a condition of extreme aloneness (Kanner 1968). ASD is characterized by 
impairments in social interaction, lack of verbal and non-verbal communications, stereotyped 
repetitive behaviours and hyperactivities to sensory inputs [1]. The lifetime prevalence of 
ASD is about 1 in a 100. Signs of ASD usually seen before two years of age and persist into 
adulthood [2]. Some studies claimed diagnosis of autistic features in children younger than 1 
year [3, 4]. It has become a substantial socio-economic burden on modern societies [5]. The 
Global Burden of Disease has ranked ASD within the scope of mental disorder burden in the 
1993 World Development Report [6]. It is the leading cause of disability in children under 
five years of age, and ASD alone is among the 20 leading causes of disabilities from all 
diseases and injuries in Western Australia [7]. Pronounced increase in its prevalence has been 
observed during the last 20 years [8]. Some researchers have claimed that this apparent rise in 
the prevalence is due to a greater level of awareness in parents or due to the diagnostic 
criteria having been changed [9, 10] while some researchers believe that this increase is a true 
reflection of the situation, citing an alteration in external environmental risk factors as 
responsible for this sharp increase [11, 12]. In this review we will concentrate on the 
emerging evidence that shows how developmental vitamin D (DVD) deficiency may 
exacerbate numerous events believed to be operating in this disease and suggest future 
research targets aimed at clarifying this relationship. 
2. Maternal vitamin D deficiency as a risk factor for ASD  
The association between vitamin D and ASD was first proposed by Dr. John Cannell [13]. 
Epidemiological studies have suggested a potential role for vitamin D deficiency in the 
development of ASD [14-18]. A California based study found that children conceived in 
winter have a 16% elevated risk of ASD diagnosis compared with the children conceived in 
summer [19]. The effect of season on ASD occurrence has been replicated in other studies 
based in Boston, Denmark and Sweden [20-22]. These authors concluded that deficiency of 
vitamin D in pregnant women due to less ultraviolet B radiation may be a plausible 
etiological factor for the high prevalence of ASD in children conceived in winter. More 
importantly, there is direct analytical epidemiological support for this proposal. In a recent 
systemic review, 9 out of 12 studies clearly show significantly lower levels of vitamin D in 
ASD children compared to controls [14]. Another meta-analysis of over 800 autistic 
individuals found that individuals with ASD had lower vitamin D than the healthy controls 
[23]. Increased prevalence of ASD has also been found in the children of vitamin D deficient 
Somali mothers [15]. Maternal vitamin D deficiency is more profound in the children of 
dark-skinned mothers unable to synthesise sufficient vitamin D [24].    
There is also indirect support for maternal or DVD-deficiency increasing ASD risk. In a 
study in Swedish born autistic and healthy siblings who shared the same environment and 
genetic background, siblings born in spring were more likely to develop ASD than the sibling 
born during other seasons. Interestingly, in a later study autistic siblings had significantly 
lower blood level of vitamin D at birth compared with non-affected siblings [25].     
3. Other risk factors for ASD 
Like all complex psychiatric conditions, ASD involves both genetic and environmental 
factors which interact to presumably adversely affect brain development. Abnormalities have 
been found in multiple genes functionally linked with ASD each with small individual effects 
[26]. ASD is a familial and highly (50-80%) heritable disorder [27, 28]. Monozygotic twins 
have high concordance rate (50%) in comparison with dizygotic twins (15-20%) [29, 30]. 
Incomplete concordance rates for monozygotic twins and phenotypical variabilities indicate 
the likely influence of environmental risk factors in the development of ASD. A growing 
body of evidence has revealed the association of several prenatal environmental risk factors 
for ASD such as advanced paternal age, being male, obstetric complications, maternal 
infections and stress during pregnancy [31] [32] [33]. 
 Evidence indicates that the offspring of aged parents and grandparents are at increased risk 
of ASD [34-36]. De novo mutations in the male germ cell line due to advanced age is a 
possible explanation of high occurrence of ASD in such children [37-39]. ASD is four to five 
times higher in males than in females [40]. The reasons behind gender biased ASD 
prevalence are still not clear. Sex steroids particularly testosterone and estradiol may have a 
role here as they have been shown to differentially regulate novel ASD related genes, for 
example retinoic acid-related orphan receptor-alpha [41].  
Obstetric complications may increase the risk of ASD. Obstetric complications linked with 
ASD include maternal bleeding, gestational diabetes, preeclampsia and maternal hormonal 
imbalances [42-46]. Infection during pregnancy is also a well-recognized environmental risk 
factor for ASD [47]. Maternal viral infection in the first trimester and bacterial infections in 
the second trimester are highly associated with ASD [48, 49]. Maternal stress during mid to 
late gestation is associated with increased risk of ASD. Studies showed that fetuses exposed 
to stress during last two trimesters had 3.8 times higher risk of developing ASD [33, 50].  
An under-recognised feature of this diverse risk-factor epidemiology is that many of these 
risk-relationships may be regulated by DVD-deficiency (Fig.1). Vitamin D deficiency is 
directly linked with several maternal factors such as gestational diabetes, preeclampsia, 
dysregulated steroidogenesis, maternal depression and infection [51, 52]. Additionally, 
vitamin D supplementation during pregnancy has been shown to reduce the risk of 
complicated pregnancies and obstetric complications [53]. Vitamin D also plays an important 
role in modulation of immune responses against infection and gestational hypovitaminosis D 
is associated with bacterial vaginosis [54]. Collectively, these observations suggest that 
DVD-deficiency may modulate or even amplify the effects of other developmental ASD risk-
factors.  
4. Vitamin D and brain  
Vitamin D is potent neurosteroid, which mediates numerous actions in several body tissues 
including brain. Immunohistochemical presence of vitamin D synthesizing enzyme CYP27B1 
and catabolic enzyme, CYP24A1, in neural cells of cerebral cortex and cerebral Purkinje 
cells suggest vitamin D can be formed locally in the brain [55-57]. Localization of CYP27B1 
in human fetal brain suggests this steroid may also exert influence in the developing brain 
[58]. Like other steroid hormones, vitamin D exerts its actions via both genomic and non-
genomic pathways [59]. Genomic actions are mediated by binding of vitamin D to the 
vitamin D receptor (VDR) which is a member of nuclear receptor super family. Vitamin D-
VDR complex heterodimerizes with retinoid X receptor and binds to vitamin D response 
elements (VDREs) within the target gene to regulate its expression. The presence of VDR has 
been confirmed in adult and embryonic (E) rodent brain [56, 60-62]. 
Vitamin D mediates its rapid non-genomic actions through several pathways. One of these 
non-genomic pathways involves membrane bound VDR. Non-genomic actions involve 
several signalling pathways mediated by kinases and phosphatases [59]. A novel vitamin D 
binding receptor protein 1,25D3-MARRS has been identified involved in the rapid non-
genomic actions of vitamin D [63]. The activities of 1,25D3-MARRS have been detected in 
newborn and adult rat brains [64].      
5. Animal models of vitamin D deficiency and the developing brain 
The impacts of maternal vitamin D deficiency on fetal brain development have been widely 
studied using a Sprague-Dawley rat model of DVD deficiency in our laboratory. This model 
was developed by feeding vitamin D depleted diet (Specialty Feeds, WA) to the females for 
the period of six weeks before mating. Dams remain on this diet until birth. The diet has 
normal levels of calcium and phosphorus. The developing fetus is totally dependent on the 
availability of vitamin D from the dam. Lack of vitamin D in maternal circulation induces 
vitamin D deficiency in developing the fetus. Several clinical studies have shown a positive 
correlation among the levels of 25-hydroxyvitamin D (25OHD) in maternal and fetal blood 
[65-67].  
Most of the studies mentioned below have been conducted using the same DVD-deficient 
model unless otherwise described. DVD-deficient animals exhibit a number of 
neurodevelopmental alterations of potential relevance to ASD. For example, brain structural 
abnormalities include an enlarged brain at birth, increased lateral ventricle volumes, 
increased overall cell proliferation and altered neurotransmission [61, 68]. In behavioural 
domains the most replicated finding is hyperlocomotion, increased sensitivity to N-methyl-D-
aspartate (NMDA) antagonists and reduced cognitive functions [61, 69, 70]. 
6. Pathophysiology of ASD and role of vitamin D 
The exact pathophysiology and mechanisms underlying ASD are still poorly understood. 
However DVD-deficiency in animal models has been shown to reproduce phenotypes of 
relevance to ASD in the domains of neuroanatomy, expression of certain molecular factors 
and steroidogenesis.  
6.1. Neuroanatomical changes in ASD and DVD-deficiency  
Autistic children exhibit initial brain overgrowth followed by abnormally slowed growth later 
in life [71, 72]. Total brain volume is reported to stay higher even after correcting for body 
height and length [73-75]. Cross sectional and longitudinal magnetic resonance imaging 
(MRI) studies have shown that ASD children from birth to 12 months of age had abnormally 
large brain volumes compared with age matched control children [76-78]. Early brain 
enlargement is associated with the increased cerebral gray matter, enlarged lateral ventricles 
and striatum [79, 80]. At the cellular level, enlargement of ASD brains involves an excess 
number of neurons in the prefrontal and dorsolateral prefrontal cortex [81, 82]. These 
findings suggest altered cell proliferation and differentiation in autism. Consistent with this 
proposal cell cycle length in ASD derived induced pluripotent stem cell is reduced. This may 
contribute an overall increase in cell proliferation in ASD [83].      
The effects of DVD-deficiency on neuroanatomy and neural cell proliferation have been 
studied in newborn rat pups. These pups had larger and longer brains along with enlarged 
lateral ventricles and thinner neocortex in comparison with control pups. These changes in 
the brain structure were associated with generalized increased cellular proliferation [61]. This 
finding was accompanied by reduced expression of apoptotic genes in vitamin D depleted 
brains compared with controls [84]. Moreover neurospheres cultured from the subventricular 
zone of DVD-deficient brains showed increased numbers of neurospheres [85]. Neurospheres 
are floating clusters of neural stem cells that can be obtained by exposing progenitor cells to 
different growth factors [86]. Adult CYP27B1 null mice lacking ability to produce the active 
vitamin D hormone also showed increased cellular proliferation in dentate gyrus [87]. Taken 
together, these finding suggest that low gestational vitamin D leads to increased cell 
proliferation, reduced apoptosis and de-differentiated fetal brain.  
Vitamin D has pleiotropic effects in several tissues including brain. Vitamin D 
supplementation promotes anti-mitotic activities and reduced cell division in hippocampal 
cells along with increased neurite growth [88]. Vitamin D has been shown to prevent cell 
proliferation by inducing cyclin-dependent kinase inhibitors p21 and p27 in different cells 
[89, 90]. Vitamin D prevents expression of other proteins required for cell cycle such as 
proliferating cell nuclear antigen and cyclin D1 [91]. Anti-apoptotic protein encoded by Bcl2 
gene is also enhanced by vitamin D, which further increase cell proliferation in hippocampal 
neurons.  
6.2. DVD-deficiency induces calcium signalling abnormalities in the brain with 
relevance to ASD 
Calcium signalling is critical for normal dendritic growth and synaptic transmission [92]. 
Calcium homeostasis is vital for neuronal survival and elevated calcium level is a well-
established cause of brain excitoxicity [93]. Not surprisingly cells in the brain are equipped 
with complex mechanisms for regulation of calcium involving voltage gated and ligand gated 
calcium channels. Dysregulation of these channels leads to abnormal intracellular calcium 
homeostasis.  
ASD associated mutations have been seen in genes encoding calcium channels and calcium 
regulated ion channels [94-96]. Both the L-type voltage-sensitive calcium channel (L-VSCC) 
and T- type calcium channels are abnormally regulated in ASD [97].   
The DVD-deficient adult rat exhibits dysregulated calcium regulating genes such as voltage-
dependent anion channel 1and calnexin [64]. Furthermore, CYP27B1 KO mice lacking active 
form of vitamin D displayed calcium toxicity by upregulation of L-VGCC expression in 
subgranular zone and granular cell layer within the hippocampal region [87]. An increase in 
L-VSCC density is associated with hippocampal cell death [98].Vitamin D protects brain 
from calcium induced toxicity by downregulating L-VSCC expression in hippocampal and 
cortical neurones. This occurs through reduction of alpha(1C) and alpha(1D) subunits of L-
VSCC [99, 100]. The addition of vitamin D has been shown to decrease (37%) membrane 
density of functional L-VSCC in hippocampal neurons [100]. These findings suggest that 
vitamin D is important for neural haemostasis and DVD-deficiency may disrupt calcium 
signalling. This is one possible mechanism linking vitamin D deficiency and ASD.  
6.3. Mitochondrial dysfunctions and oxidative stress  
A growing body of evidence suggests that mitochondrial dysfunction (MD) and oxidative 
stress (OS) could play some role in the onset of ASD [101, 102]. About one in twenty 
individuals with ASD have been diagnosed with MD [101]. A population based study in 
Portugal and Azores Islands screened 120 autistic children. This study concluded that 7.2% 
of autistic children met the criteria for MD [103]. Higher blood levels of pyruvate, lactate, 
pyruvate-lactate ratio and increased metabolism of pyruvate to lactate and alanine has been 
found in ASD children [103-105]. A postmortem study has found deficiencies in electron 
transport complexes and pyruvate dehydrogenase in frontal cortices of autistic brain 
compared with controls [106]. Magnetic resonance spectroscoy (MRS) studies showed 
decreased levels of N-acetylaspartate in amygdala, orbito-frontal cortex and cerebellum of 
autistic brains [107, 108]. 
Mitochondria localized in brain are involved in calcium homeostasis and energy production. 
These processes produce a high amount of reactive oxygen species [109]. The depletion of 
glutathione exposes the brain to OS [110]. ASD children have significant high concentrations 
of plasma nitric oxide and hydrogen peroxide [111, 112]. A recent meta-analysis from 29 
studies found 27% reduction in reduced glutathione, 18% reduction in glutathione peroxidase 
and 45% elevation in the level of oxidized glutathione in the blood of autistic children than 
control [113]. 
Vitamin D deficiency induces MD and OS by dysregulating expression of several 
mitochondrial enzymes localized in the frontal cortex and hippocampus of DVD-deficient 
rats when measured as adults. These enzymes include ATP synthase β-chain, cytochrome c 
oxidase, cytochrome b5, ATPase H+ transporting V1 B2 and electron transfer flavoprotein 
complex [64, 114]. Oxidative phosphorylation and redox balance are two processes disrupted 
in the DVD-deficient brains. DVD-deficiency also downregulates several mitochondrial 
proteins in the nucleus accumbens such as NADH dehydrogenase 1 α subunit 10, pyruvate 
dehydrogenase E1 component subunit β and isocitrate dehydrogenase 3 α [115]. DVD-
deficiency may increase OS in rat brains by decreasing expression of anti-oxidative enzymes 
such as catalase and Mn-containing superoxide dismutase [64]. 
Vitamin D has been shown to inhibit production of nitric oxide synthase in neural cells [116]. 
Glutathione, an important antioxidant and mostly involved in the removal of nitric oxide is 
reported to be enhanced by vitamin D in newborn rat astrocytes [117]. Vitamin D promotes 
other molecules involve in glutathione biosynthesis including glutamate cysteine ligase and 
glutathione reductase [118]. Collectively, these studies show that vitamin D may confer a 
protective role at mitochondrial level and DVD-deficiency may contribute to MD and OS in 
the brains of ASD individuals.  
6.4. Neurotransmission     
6.4.1. Glutamatergic and gamma-aminobutyric acid abnormalities 
Glutamate and gamma-aminobutyric acid (GABA) are two important neurotransmitters that 
are connected to extensive synaptic communication in brain. Glutamate is metabolized by 
glutamic acid decarboxylase 65 (GAD65) and glutamic acid decarboxylase 67 (GAD67) to 
GABA. Many studies have reported dysregulation in glutamatergic and GABAergic 
neurotransmission in autistic brains. Abnormal levels of glutamate and reduced expression of 
glutamate metabolizing enzymes have been reported in the brain of ASD individuals. One 
study showed significantly higher levels of glutamate and glutamine in amygdala and 
hippocampal regions of adult ASD brain compared with controls [119]. In contrast to this, 
another study has shown reduced subcortical glutamate and glutamine in adult ASD brains 
[120]. The cerebellum is one brain region repeatedly shown to be implicated in ASD. The 
cerebellum mediates motor coordination, cognitive and sensory functions. A comprehensive 
post-mortem study have shown reduced (48–60%) protein levels of GAD65 and GAD67 in 
cerebellar and parietal cortices of autistic brains compared with age matched control brains 
[121]. A significantly reduced level of GAD65 and GAD67 mRNA in cerebellar Purkinje 
cells and cerebellar dentate nuclei of ASD brains has also been reported [122, 123]. It has 
even been suggested that the stereotyped repetitive behaviours found in ASD is in part due to 
reduced inhibitory control in autistic brains. 
DVD-deficiency decreases gene expression of GABA-Aα4 receptor in newborn [124] and 
NMDA receptor density in the adult rat brain [125]. The impacts of vitamin D deficiency 
were also examined in adult mice which were vitamin D depleted for 10 weeks before testing. 
Adult vitamin D deficient mice had significantly lower protein levels of both GAD65 and 
GAD67 [126].  
Vitamin D protects brain against glutamate induced neurotoxicity by upregulating VDR 
expression in rat cortical neurons [127]. Chronic treatment of rodents with vitamin D further 
increases GABA synthesis in several brain tissues including prefrontal cortex, anterior 
cingulate cortex and hippocampus [128, 129]. Interestingly, the same study has found 
upregulation of GAD65 and GAD67 in limbic regions and hippocampus respectively [129]. 
Therefore diminished regulation of inhibitory control induced by vitamin D deficiency may 
in part explain the repetitive behaviours found in ASD.  
6.4.2. Dopamine 
Dopamine (DA) is a neurotransmitter in the brain that plays important role in several 
behavioural domains such as motor control, reward-motivation, regulation of emotions and 
social interaction [130, 131]. There is a small amount of evidence that DA signalling may be 
altered in patients with ASD [132, 133]. De novo mutations have been found in DA 
transporter (DAT) gene (SLC6A3) in ASD individuals [133]. DAT is a membrane protein 
localized on nerve terminal and regulates transmission of synaptically released DA across the 
membrane and plays important role in maintaining DA homeostasis in the brain [134]. 
Polymorphism of a major DA catabolic enzyme (catechol-O-methyltransferase (COMT) have 
also been found in several ASD populations [135-137]. 
Altered DA signalling is a persistent finding in DVD-deficient rat model. DVD-deficiency 
may alter DA turnover by decreasing the expression of COMT in neonatal rat brains [68].  
Interestingly, vitamin D treatment increases COMT gene expression in SH-SY5Y cells [138]. 
DVD-deficient embryonic brains exhibit decreased expression of genes required for DA 
specification such as Nurr1 and p57(Kip2) [139]. Both Nurr1 and p57(Kip2) are critical for 
DA neuron development and maturation [140]. DVD-deficient adults have elevated levels of 
DAT and increased binding affinity for DAT ligands in caudate putamen and nucleus 
accumbens [141]. Increased uptake of DA due to elevated levels of DAT results in OS and 
neuronal damage [142]. Vitamin D has also been shown to increase production of tyrosine 
hydroxylase (DA synthesising enzyme) and DA metabolites such as homovanillic acid and 3 
methoxytyramine in VDR expressing neuroblastoma SH-SY5Y cells [138, 143]. 
6.4.3. Serotonin  
Serotonin is an important neurotransmitter and plays significant role in neurogenesis and 
neuronal differentiation during brain development [144]. Few studies have shown abnormal 
serotonin system in ASD brain. A positron emission tomography study of autistic and non-
autistic adults found low serotonin transporter binding throughout the autistic brain 
particularly in anterior and posterior cingulate cortices [145]. ASD post-mortem brains show 
low densities of serotonin receptors including 5-HT1A and 5-HT2A in fusiform gyrus 
compared with controls [146]. Serotonin synthesis capacity is also compromised in frontal 
cortex, thalamus and cerebellum of ASD individuals [147]. In contrast to a relative decrease 
in serotonin signalling in the ASD brain, autistic patients have a significantly high level of 
serotonin in blood compared to healthy individuals. Hyperserotonemia is found in 30% ASD 
patients and their first degree relatives [148, 149]. 
Vitamin D treatment upregulates the serotonin synthesizing gene tryptophan hydroxylase 2 
(THP2) in human and rat glioblastoma cell lines [150]. Moreover, sub-chronic treatment of 
rats with high dose of vitamin D induced expression of TPH2 and monoamine oxidase A, 
which increased concentration of 5-hydroxyindoleacetic acid (major serotonin metabolite) 
without changing serotonin status in prefrontal cortex [129]. It has been suggested that 
Vitamin D may induce the THP2 in brain and repress TPH1 in gut as central mechanisms in 
ASD [151]. This has yet to be demonstrated in patients or any ASD model. 
The impacts of vitamin D deficiency on serotonin system have been observed in adult 
vitamin D deficient mice. The level of 5-hydroxyindoleacetic acid was significantly increased 
in the brains of these mice compared to the controls. The ratio of serotonin to 5-
hydroxyindoleacetic acid was also altered which may reflect an increase in serotonin turnover 
in vitamin D deficient brains [126].  
6.5. DVD-deficiency alters immune function; relevance to ASD 
There is a well-established association between maternal infection and increased incidence of 
ASD in children. Maternal cytokines can cross the fetal blood brain barrier through placenta 
and lead to neuro-inflammation in developing brain [152]. A number of post-mortem studies 
have suggested that ASD brains have on going neuro-inflammation regardless of age [153-
156]. In general neuro-inflammation is characterized by activation of the inflammatory cells 
in the brain astrocytes and microglia. These cells, particularly microglia which are the major 
phagocyte-like cell in the brain, when stimulated increase expression of cytokines and 
chemokines. Activated microglia and increased microglial density have been found in 
dorsolateral prefrontal cortex of autistic brain [157]. Persistent ongoing inflammation leads to 
loss of connectivity and neural cell death [158].  
A growing number of studies suggest that vitamin D induces an anti-inflammatory response 
in several tissue types including brain [159, 160].  The proof of concept that vitamin D 
modulates immune systems arises from the fact that VDR is present in almost all immune 
cells including neutrophils, macrophages, T cells, B cells and dendritic cells (DC) [161, 162]. 
Vitamin D inhibits synthesis of pro-inflammatory cytokines by targeting mitogen-activated 
protein kinase phosphatases which are essential in the regulation of immune responses [163]. 
Vitamin D via its genomic actions inhibits propagation of uncommitted T helper cells and 
promotes production and accumulation of immunosuppressive T regulatory cells at the site of 
inflammation [164]. It also suppresses proliferation of activated B lymphocytes, suggesting 
an anti-inflammatory role of vitamin D in autoimmune diseases [165]. The absence of dietary 
vitamin D may therefore have implications for normal immune function. 
DVD-deficiency in rats induced persistent changes in the morphology of immune organs such 
as enlarging spleen and thymus [166]. Cultured lymphocytes from DVD-deficient offspring 
exhibited increased levels of IL-2 and IL-10 after a ionomycin challenge [166]. The effects of 
vitamin D deficiency were also examined on microglial phagocytic rates that were stimulated 
with toll like receptor (TLR) agonists lipopolysaccharide (LPS) and 
polyinosinic:polycytidylic acid (poly I:C). After such treatment DVD-deficient microglial 
cells engulfed fewer E.coli than cells exposed to normal levels of vitamin D [167]. Vitamin D 
deficiency also decreased the immune response of microglial cells by reducing production of 
TNF-α and IL-6 [167]. Additionally, VDR and CYP27B1 knockout mice are more vulnerable 
to exogenously induced inflammatory bowel disease [168-170]. VDR null mice are sensitive 
to dextran sodium phosphate and show significant high expression several cytokines 
including of IL-1β, TNF-α, IL-10 and INF-γ compared with wild type mice [171]. Taken 
together then, DVD-deficiency may lead to increased inflammatory outcomes associated with 
ASD. 
6.6. Steroid dysregulation in ASD and vitamin D 
Studies have consistently shown that males are over-represented four-fold in ASD [40, 172]. 
Sex steroids particularly testosterone and estradiol may be crucial here. The brain develops 
differentially in both sexes because of exposure to distinct steroid hormones. It is 
hypothesized that hypermasculinization due to exposure of high levels of prenatal 
testosterone leads to extreme manifestation of cognitive and emotional behaviour observed in 
ASD individuals [173, 174]. Consistent with this, significantly higher levels of androgens and 
testosterone have been reported in the saliva and urine of ASD individuals [175, 176]. 
Another study found higher levels of testosterone in the amniotic fluid of the children who 
were later diagnosed of having autistic traits [177]. The mRNA levels of estrogen 
synthesizing enzyme aromatase and estrogen receptor β are decreased by 38% and 35% 
respectively in middle frontal gyrus of ASD brains compared with healthy brains [178]. 
Genetic studies revealed associations of steroidogenic enzymes with ASD including 
CYP17A1, CYP11B1 and aromatase [179]. These enzymes are involved in the conversion of 
cholesterol into different steroids such as progesterone, 17α hydroxy-progesterone and 
estrogen. Interestingly, a recent study using the Danish Historic Birth Cohort has found 
elevated levels of several steroids including progesterone, 17α hydroxy-progesterone, 
androstenedione, testosterone and cortisol in the amniotic fluid of ASD children [180]. 
Elevated corticosterone levels and abnormal activation of hypothalamic–pituitary–adrenal 
(HPA) axis has also been cited in ASD individuals [181-183]. Together, these studies suggest 
that ASD is associated with a dysregulation of steroidogenic activities mediated by 
cytochrome P450 and other enzymes involved in steroid synthesis.  
Vitamin D has been shown to regulate the expression and synthesis of many steroids. Clinical 
studies in 1959 found a negative correlation between the concentrations of vitamin D and 
urinary androstenedione and dehydroepiandrosterone (DHEA) [184].  
Vitamin D deficiency has been shown to increase circulatory glucocorticoid concentrations in 
pregnant mice [185, 186]. Glucocorticoids are lipophilic compounds that can diffuse from 
placenta to the fetal circulation. The placental expression of HSD11β2 protects the fetus from 
glucocorticoid exposure by inactivating corticosterone to 11-dehydrocorticosterone. DVD-
deficiency further exposes the developing fetus to higher levels of maternal glucocorticoids 
by reducing the expression of HSD11β2 in placenta [185]. However by adulthood it would 
appear that HPA function was normal in DVD-deficient offspring [186]. Ablating the VDR 
induces abnormalities in both male and female steroidogenesis. VDR mutant male mice 
showed transient increase in testicular weight but testosterone level was not measured. 
However female VDR null mouse from this same study had dysfunctional ovaries and these 
animals were unable to produce sufficient estrogen. Aromatase activity was also reduced in 
ovaries and testicles of VDR knockout mice along with decreased levels of estrogen in the 
blood [187]. 
In vitro, vitamin D has been shown to regulate expression of steroidogenic enzymes in 
different non-neural cell lines. It induced activation of CYP11A1 and CYP17A1 and 
decreased synthesis of androstenedione, DHEA, DHEA-sulphate and corticosterone in human 
adrenocortical carcinoma cells [188]. The testosterone catabolic enzyme HSD17β2, was 
found to be upregulated by vitamin D [189]. Vitamin D exhibits tissue specific effects on the 
expression of the major catabolic enzyme for testosterone, aromatase [190]. Vitamin D 
increases estrogen and progesterone synthesis in cultured human trophoblast cells [191], 
whereas in breast cancer cells, aromatase expression was reduced following vitamin D 
treatment [192]. The impact of vitamin D deficiency has not been studied on steroidogenic 
activities of these enzymes in DVD-deficient model. Future studies need to address if this is a 
contributing mechanism to ASD.  
7. Vitamin D and placental functions 
Placenta becomes an active site of extra-renal synthesis of vitamin D and contributes 20-50% 
of the circulating vitamin D in pregnancy [193, 194]. Locally produced vitamin D facilitates 
maternal immune tolerance by inducing expression of VDR and CYP27B1 in placental 
immune cells [195, 196]. In vitro studies showed that vitamin D prevents maturation and 
differentiation of placental DC by reducing cell surface expression of major 
histocompatibility complexes [197]. It is worth noting that during the first trimester, placental 
DC become tolerogenic becoming less capable of presenting antigens compared with 
maternal DCs [198, 199]. The role of vitamin D also been studied in placenta in the presence 
of an exogenous immune challenge. Both in vivo and in vitro LPS exposure induces 
CYP27B1 and VDR expression which again is consistent with vitamin D signalling being 
anti-inflammatory [200]. Genetic ablation of CYP27B1 or VDR leads to increased placental 
inflammatory cytokines in response to an LPS challenge [200].  
8. ASD-related behavioral phenotypes in DVD-deficient animals  
8.1. Ultrasonic vocalizations 
Impairments in verbal communications suggest language delays and poor pragmatics in ASD 
individuals. Interestingly, some studies found unusual patterns of vocalizations in ASD 
infants [201, 202]. Obviously rodents do not use language for communication but rather they 
emit ultrasonic Vocalizations (USV) in different situations. For example, neonates emit USV 
when isolated from mother and littermates, juveniles during social play and adults during 
mating and aggression [203]. Reduced USV have been reported in some genetic and 
environmental animal models of neurodevelopmental diseases including ASD [204-206]. The 
patterns of USV emitted from a pup isolated from its nest initiate exploratory and retrieval 
behaviour in mothers [203]. Evidence shows that dams spend more time with pups vocalizing 
at high amplitude than the pups with low amplitude [207]. USV by newborn pups and 
maternal retrieval behaviours have been studied in DVD-deficient animals. There was no 
significant effect of diet on USV and calling pattern by pups, however the DVD-deficient 
dams retrieved their pups earlier and spent more time with them than the control dams [208]. 
Because pup USV have been shown to alter maternal retrieval behaviour, it was speculated 
that altered maternal retrieval behaviour in DVD-deficient dams was due to alteration in the 
calling amplitude of their pups.  
8.2. Stereotyped repetitive behaviour 
Stereotyped repetitive behaviour has been considered central to ASD. Autistic children show 
stereotyped movements such as hand or finger flapping, spinning and jumping [1]. 
Spontaneous motor stereotypies can be modelled in rodents by assessing the time spent on 
self-grooming, circling, jumping or excessive digging [209].  Interestingly, significant effect 
of maternal diet has been found on the grooming frequency in juvenile rats. DVD-deficient 
juvenile rats showed significantly more grooming behaviour than the vitamin D sufficient rats 
[210].       
8.3. Anxiety-related behaviour 
Children with anxiety disorders score high for ASD traits compared to healthy children [211, 
212]. There is an overlap in behavioural characteristics between children with ASD and 
anxiety disorders with respect to Diagnostic and Statistical Manual of Mental Disorders-IV-
TR diagnostic criteria [213]. In fact anxiety related concerns are common in toddlers who 
develop ASD [214].  
Open field exploration and behaviours in the elevated plus maze are well established and 
validated tests to assess anxiety-like behaviours in rodents [215]. Usually, rodents spent more 
time in the periphery compared to the central area of an open field. Time spent in the central 
area is considered a measure of non-anxious behaviour [215]. In an open field test, adult 
DVD-deficient rats spend more time in the sides and less time in the corners compared with 
controls suggesting some form of anxious behaviour in DVD-deficient rats [216]. However, 
in an EPM which is a reliable measure of anxiety in rodents DVD-deficient rat behaviour was 
normal (Burne 2004).  
8.4. Hyperlocomotion 
Children with ASD show hyperactivity to sensory inputs [1]. Hyperlocomotion is one of the 
most consistent findings in DVD-deficient rats, which has been observed across different 
behavioural tests including open field, elevated plus maze and hole-board [69, 217]. Both 
DVD-deficient adult rats and mice show spontaneous hyperlocomotion [186, 218]. DVD-
deficiency induced hyperlocomotion is independent of HPA-axis as these animals had normal 
corticosterone release in response to restraint stress [186]. Juvenile DVD-deficient rats 
travelled further when vitamin D deficiency was extended until weaning. Similar to these 
observations, DVD-deficiency increased sensitivity to psychostimulant induced locomotion 
in adult rats during open field testing [69, 125, 141]. Systemic injections of the NMDA 
antagonist MK-801 or amphetamine increased hyperlocomotion in DVD-deficient rats 
compared with controls. These findings suggest DVD-deficiency is associated with impaired 
NMDA receptor and DA signalling. Interestingly, administration of DA and NMDA 
antagonist haloperidol eliminates both spontaneous and MK-801 induced locomotion in 
DVD-deficient animals [69].  
9. Conclusion and future directions 
In this review we have summarized fundamental pathways that may be key targets in 
understanding the pathophysiology of ASD. We have outlined the impact that vitamin D 
deficiency may have on the regulation of these pathways both in vivo and in vitro. Both 
human and animal studies suggest that an optimal level of vitamin D during development and 
early life is important to avoid ASD-like behavioural phenotypes. The DVD-deficiency 
model we have developed is an ideal experimental platform to explore molecular mechanisms 
linking DVD-deficiency and development of ASD. We think it highly likely that the 
molecular mediating mechanisms between DVD-deficiency and ASD are likely to involve 
both direct regulation of the fetal/placental immune response and alterations in 
steroidogenesis. However our model requires 2 major alterations. First, to date we have 
explored behaviours primarily in adults. We now wish to assess ASD relevant behaviour in 
DVD-deficient young and juvenile animals mimicking the period of ASD onset. Second, to 
date we have restricted the period of vitamin D deficiency to gestation in the rat. This is 
inadequate when assessing the effects of vitamin D deficiency across an equivalent period of 
primate brain development. Therefore we wish to now extend the period of DVD-deficiency 
to weaning. DVD-deficient model may prove relevant for the investigation of possible 
therapeutic strategies to reverse both these putative mechanisms and optimally ASD-like 
phenotypes. DVD-deficiency may only represent one environmental factor contributing to 
this disease. However the ability to intervene with such a simple, safe and affordable factor 
during pregnancy makes this an important public health concern. 
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Fig. 1: DVD-deficiency interacts with wide range of other environmental risk factors to 
modulate multiple pathophysiological processes relevant to ASD    
 
 
 
 
